{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:20:39Z","timestamp":1773868839993,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP16\/00041"],"award-info":[{"award-number":["CP16\/00041"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["1369\u2013341"],"award-info":[{"award-number":["1369\u2013341"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"FEDER","doi-asserted-by":"crossref","award":["POCTEFA 2014-2020"],"award-info":[{"award-number":["POCTEFA 2014-2020"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00415-019-09610-8","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T18:02:59Z","timestamp":1573149779000},"page":"543-550","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt\u2013Jakob disease: a comparative prospective study with 14-3-3"],"prefix":"10.1007","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9756-7497","authenticated-orcid":false,"given":"Franc","family":"Llorens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Villar-Piqu\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Waniek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingolf","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"key":"9610_CR1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(12)70063-7","volume":"11","author":"G Puoti","year":"2012","unstructured":"Puoti G, Bizzi A, Forloni G et al (2012) Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 11:618\u2013628. \nhttps:\/\/doi.org\/10.1016\/S1474-4422(12)70063-7","journal-title":"Lancet Neurol"},{"key":"9610_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2017.12.008","author":"I Zerr","year":"2018","unstructured":"Zerr I, Schmitz M, Karch A et al (2018) Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: evaluation of diagnostic accuracy in the differential diagnosis of prion diseases. Alzheimers Dement. \nhttps:\/\/doi.org\/10.1016\/j.jalz.2017.12.008","journal-title":"Alzheimers Dement"},{"key":"9610_CR3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005860","author":"P Hermann","year":"2018","unstructured":"Hermann P, Laux M, Glatzel M et al (2018) Validation and utilization of amended diagnostic criteria in Creutzfeldt\u2013Jakob disease surveillance. Neurology. \nhttps:\/\/doi.org\/10.1212\/WNL.0000000000005860","journal-title":"Neurology"},{"key":"9610_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-015-9167-5","author":"M Schmitz","year":"2015","unstructured":"Schmitz M, Ebert E, Stoeck K et al (2015) Validation of 14-3-3 protein as a marker in sporadic Creutzfeldt\u2013Jakob disease diagnostic. Mol Neurobiol. \nhttps:\/\/doi.org\/10.1007\/s12035-015-9167-5","journal-title":"Mol Neurobiol"},{"key":"9610_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","volume":"67","author":"P Sanchez-Juan","year":"2006","unstructured":"Sanchez-Juan P, Green A, Ladogana A et al (2006) CSF tests in the differential diagnosis of Creutzfeldt\u2013Jakob disease. Neurology 67:637\u2013643. \nhttps:\/\/doi.org\/10.1212\/01.wnl.0000230159.67128.00","journal-title":"Neurology"},{"key":"9610_CR6","doi-asserted-by":"publisher","first-page":"5666","DOI":"10.18632\/oncotarget.13998","volume":"8","author":"F Llorens","year":"2017","unstructured":"Llorens F, Schmitz M, Zerr I (2017) Progress in CSF biomarker discovery in sCJD. Oncotarget 8:5666\u20135667. \nhttps:\/\/doi.org\/10.18632\/oncotarget.13998","journal-title":"Oncotarget"},{"key":"9610_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mcn.2018.12.003","volume":"97","author":"AGB Thompson","year":"2019","unstructured":"Thompson AGB, Mead SH (2019) Review: Fluid biomarkers in the human prion diseases. Mol Cell Neurosci 97:81\u201392","journal-title":"Mol Cell Neurosci"},{"key":"9610_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.09.013","author":"F Llorens","year":"2016","unstructured":"Llorens F, Kruse N, Schmitz M et al (2016) Evaluation of \u03b1-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases. Alzheimers Dement. \nhttps:\/\/doi.org\/10.1016\/j.jalz.2016.09.013","journal-title":"Alzheimers Dement"},{"key":"9610_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1251-1","author":"A Villar-Piqu\u00e9","year":"2018","unstructured":"Villar-Piqu\u00e9 A, Schmitz M, Lachmann I et al (2018) Cerebrospinal fluid total prion protein in the spectrum of prion diseases. Mol Neurobiol. \nhttps:\/\/doi.org\/10.1007\/s12035-018-1251-1","journal-title":"Mol Neurobiol"},{"key":"9610_CR10","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/acn3.584","volume":"5","author":"N Ermann","year":"2018","unstructured":"Ermann N, Lewczuk P, Schmitz M et al (2018) CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD. Ann Clin Transl Neurol 5:883\u2013887. \nhttps:\/\/doi.org\/10.1002\/acn3.584","journal-title":"Ann Clin Transl Neurol"},{"key":"9610_CR11","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1001\/2013.jamaneurol.79","volume":"69","author":"RW Paterson","year":"2012","unstructured":"Paterson RW, Torres-Chae CC, Kuo AL et al (2012) Differential diagnosis of Jakob\u2013Creutzfeldt disease. Arch Neurol 69:1578\u20131582. \nhttps:\/\/doi.org\/10.1001\/2013.jamaneurol.79","journal-title":"Arch Neurol"},{"key":"9610_CR12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/14737175.2018.1519397","volume":"18","author":"I Zerr","year":"2018","unstructured":"Zerr I, Hermann P (2018) Diagnostic challenges in rapidly progressive dementia. Expert Rev Neurother 18:761\u2013772","journal-title":"Expert Rev Neurother"},{"key":"9610_CR13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/B978-0-444-63945-5.00020-9","volume-title":"Human Prion Diseases","author":"Michael D. Geschwind","year":"2018","unstructured":"Geschwind MD, Murray K (2018) Differential diagnosis with other rapid progressive dementias in human prion diseases. In: Handbook of clinical neurology. pp 371\u2013397"},{"key":"9610_CR14","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr I, Kallenberg K, Summers DM et al (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt\u2013Jakob disease. Brain 132:2659\u20132668. \nhttps:\/\/doi.org\/10.1093\/brain\/awp191","journal-title":"Brain"},{"key":"9610_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3233\/JAD-160448","volume":"55","author":"P Lewczuk","year":"2016","unstructured":"Lewczuk P, Lelental N, Lachmann I et al (2016) Non-phosphorylated tau as a potential biomarker of Alzheimer\u2019s disease: analytical and diagnostic characterization. J Alzheimers Dis 55:159\u2013170. \nhttps:\/\/doi.org\/10.3233\/JAD-160448","journal-title":"J Alzheimers Dis"},{"key":"9610_CR16","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/nprot.2016.120","volume":"11","author":"M Schmitz","year":"2016","unstructured":"Schmitz M, Cramm M, Llorens F et al (2016) The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases. Nat Protoc 11:2233\u20132242. \nhttps:\/\/doi.org\/10.1038\/nprot.2016.120","journal-title":"Nat Protoc"},{"key":"9610_CR17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837. \nhttps:\/\/doi.org\/10.2307\/2531595","journal-title":"Biometrics"},{"key":"9610_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A et al (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. \nhttps:\/\/doi.org\/10.1186\/1471-2105-12-77","journal-title":"BMC Bioinform"},{"key":"9610_CR19","unstructured":"Stock C, Hielscher T (2014) DTComPair: comparison of binary diagnostic tests in a paired study design. R package version 1.0.3. \nhttps:\/\/CRANR-project.org\/package=DTComPair\n\n. Accessed 2014"},{"key":"9610_CR20","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1007\/s12035-015-9133-2","volume":"53","author":"M Cramm","year":"2016","unstructured":"Cramm M, Schmitz M, Karch A et al (2016) Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt\u2013Jakob disease. Mol Neurobiol 53:1896\u20131904. \nhttps:\/\/doi.org\/10.1007\/s12035-015-9133-2","journal-title":"Mol Neurobiol"},{"key":"9610_CR21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ana.23589","volume":"72","author":"LI McGuire","year":"2012","unstructured":"McGuire LI, Peden AH, Orru CD et al (2012) Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt\u2013Jakob disease. Ann Neurol 72:278\u2013285. \nhttps:\/\/doi.org\/10.1002\/ana.23589","journal-title":"Ann Neurol"},{"key":"9610_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13195-017-0275-5","volume":"9","author":"J Goossens","year":"2017","unstructured":"Goossens J, Bjerke M, Struyfs H et al (2017) No added diagnostic value of non-phosphorylated tau fraction (p-taurel) in CSF as a biomarker for differential dementia diagnosis. Alzheimers Res Ther 9:49. \nhttps:\/\/doi.org\/10.1186\/s13195-017-0275-5","journal-title":"Alzheimers Res Ther"},{"key":"9610_CR23","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1093\/brain\/122.12.2345","volume":"122","author":"S Poser","year":"1999","unstructured":"Poser S, Mollenhauer B, Krau\u00df A et al (1999) How to improve the clinical diagnosis of Creutzfeldt\u2013Jakob disease. Brain 122:2345\u20132351. \nhttps:\/\/doi.org\/10.1093\/brain\/122.12.2345","journal-title":"Brain"},{"key":"9610_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/jid.2014.371","volume":"64","author":"M Geschwind","year":"2008","unstructured":"Geschwind M et al (2008) Rapidly progressive dementia. Ann Neurol 64:97\u2013108. \nhttps:\/\/doi.org\/10.1038\/jid.2014.371","journal-title":"Ann Neurol"},{"key":"9610_CR25","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/nan.12175","volume":"41","author":"F Llorens","year":"2015","unstructured":"Llorens F, Zafar S, Ansoleaga B et al (2015) Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt\u2013Jakob disease. Neuropathol Appl Neurobiol 41:631\u2013645. \nhttps:\/\/doi.org\/10.1111\/nan.12175","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9610_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm.2294","volume":"17","author":"R Atarashi","year":"2011","unstructured":"Atarashi R, Satoh K, Sano K et al (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17:175\u2013178. \nhttps:\/\/doi.org\/10.1038\/nm.2294","journal-title":"Nat Med"},{"key":"9610_CR27","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neuroscience.2016.02.057","volume":"322","author":"MJ Leit\u00e3o","year":"2016","unstructured":"Leit\u00e3o MJ, Baldeiras I, Almeida MR et al (2016) Sporadic Creutzfeldt\u2013Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3\u03b3 assay. Neuroscience 322:398\u2013407. \nhttps:\/\/doi.org\/10.1016\/j.neuroscience.2016.02.057","journal-title":"Neuroscience"},{"key":"9610_CR28","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1093\/brain\/aws238","volume":"135","author":"K Stoeck","year":"2012","unstructured":"Stoeck K, Sanchez-Juan P, Gawinecka J et al (2012) Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt\u2013Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain 135:3051\u20133061. \nhttps:\/\/doi.org\/10.1093\/brain\/aws238","journal-title":"Brain"},{"key":"9610_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt236","author":"J Toombs","year":"2014","unstructured":"Toombs J, Paterson RW, Schott JM, Zetterberg H (2014) Amyloid-beta 42 adsorption following serial tube transfer. Alzheimer\u2019s Res Ther. \nhttps:\/\/doi.org\/10.1186\/alzrt236","journal-title":"Alzheimer\u2019s Res Ther"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09610-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09610-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09610-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:11:36Z","timestamp":1604621496000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09610-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,7]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["9610"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09610-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,7]]},"assertion":[{"value":"16 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Lachmann and Dr. Waniek report they are employers of AJ Roboscreen GmbH, Leipzig, Germany. No other conflict of interest is reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was conducted according to the revised Declaration of Helsinki and Good Clinical Practice guidelines and was approved by local Ethics commitee (Reference number 11\/11\/93), Universit\u00e4tzmedizin G\u00f6ttingen, Germany).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}